Webinar Recording: Facing Tomorrow Today with Transformative CIED Management
Posted on: December 18, 2018
The burden of device management is real. Tomorrow it will only be worse. It’s estimated that by 2022, we could be facing 6X more device transmissions. That’s real change. Decisions need to be made to tackle the challenge. Solutions exist to better prepare your clinic for today and tomorrow.
• What factors drive CIED burden growth?
• Why does CIED management matter?
• Quantify the benefits of better device management
• Pirooz Mofrad, MD, FACC, FHRS
• Washington Heart Rhythm Associates
• Washington, D.C.
• Director, Electrophysiology Lab, Washington Adventist Hospital, 2013-Present
• Vice-President, Washington Adventist Hospital, Division of Cardiology, 2010-2011
University of Pittsburgh School of Medicine, 2000
Internship/Residency: Georgetown University Hospital Internal Medicine, 2003
Fellowships: Cardiovascular Disease, Georgetown University/Washington Hospital Center, 2006; Cardiac Electrophysiology, Stanford University Medical Center, 2007
American Heart Association, American College of Cardiology, Heart Rhythm Society
Published Peer Reviewed Author in:
- PACE: Pacing and Clinical Electrophysiology
- AHA Journal - Circulation
- Heart Rhythm
- Journal of Interventional Cardiac Electrophysiology
- Cardiovascular Revascularization Medicine
- New England Journal of Medicine
- EP Lab Digest
- New Advances in Nuclear Cardiology
Board Certifications & Specialties:
- Clinical Cardiac Electrophysiology, Cardiovascular Disease, Internal Medicine
Dr. Mofrad has always felt at home in medicine having both a father and sister who are physicians. Cardiovascular surgery was his intended path, until an early internship during med-school when he first discovered electrophysiology and the ability to cure arrhythmias via ablation procedures. Dr. Mofrad met EP mentors throughout his internship and residency that continued to foster his curiosity and cemented his love for treating rhythm disturbances. His professional interests include ventricular tachycardia and ablation, and catheter ablation therapies for atrial fibrillation.